IFRX InflaRx N.V.
Healthcare$2.74+4.98%ClosedMarket Cap: $198.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.39
P/S
5527.18
EV/EBITDA
-3.49
DCF Value
$0.20
FCF Yield
-17.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
-24646.3%
Operating Margin
-144445.0%
Net Margin
-146303.9%
ROE
-94.9%
ROA
-87.7%
ROIC
-112.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-7.2M | $-5.6M | $— | — |
| Q4 null | $-33.9K | 14418.5% | $-12.9M | $-10.6M | $— | — |
| FY null | $29.3K | -24677.9% | $-48.3M | $-45.6M | $— | — |
| Q3 null | $23.8K | 98.6% | $-9.5M | $-12.3M | $— | — |
| Q2 null | $39.4K | -5985.4% | $-12.8M | $-14.4M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-13.0M | $-8.3M | $— | — |
| Q4 null | $-423.00 | 666984.2% | $-9.8M | $-5.1M | $— | — |
| FY null | $165.8K | -1900.8% | $-52.9M | $-46.1M | $— | — |
| Q3 null | $123.8K | 158.6% | $-15.4M | $-17.4M | $— | — |
| Q2 null | $6.4K | -5376.7% | $-15.4M | $-13.8M | $— | — |
| Q1 null | $36.0K | -511.9% | $-12.5M | $-9.7M | $— | — |
| Q4 2023 | $2.2K | -14994.4% | $-12.8M | $-15.6M | $-0.26 | — |